drugset / Trial / NCT00418171

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

NCT00418171

Phase 4 Completed 18239 enrolled Pfizer
RandomizedSingle-groupOpen-labelTreatment

Summary

The primary objective of the study is to estimate the relative incidence among users of ziprasidone and olanzapine of non-suicide mortality.

Timeline

Start
2002-02
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule
Subject Ziprasidone Small molecule

Indications